Browse 90 Fatty Liver clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Fatty liver disease, including nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), occurs when fat builds up in the liver. This condition can lead to inflammation, liver damage, and more serious complications if untreated.
Clinical trials for fatty liver explore innovative treatments aimed at reducing liver fat and preventing progression, providing participants early access to transformative treatment options.
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
for
Metabolic Dysfunction-associated Steatohepatitis
Location: Sparta NJ, Marlton NJ, Greenbelt MD, Richmond VA,